Trial site
Bordeaux
- 11running trials
- 11closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia7 trials
- Colorectal cancer2 trials
- Hidradenitis suppurativa2 trials
- Chronic spontaneous urticaria1 trial
- Coronary artery disease1 trial
- Familial hypercholesterolaemia1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Multiple sclerosis1 trial
- Myasthenia gravis1 trial
- Myeloproliferative neoplasms1 trial
- and 2 more
- Phase
- Phase 26 trials
- Phase 36 trials
- Phase 1/23 trials
- Phase 12 trials
- Phase 2/31 trial
- Status
- Completed9 trials
- Active, not recruiting6 trials
- Recruiting5 trials
- Terminated2 trials
- Lead sponsor
- Novartis Pharmaceuticals22 trials
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic myeloid leukaemia1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Completed
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Site data: ClinicalTrials.govUpdated 17 Nov 2026